Dna

Avecia takes on new MS drug

Avecia takes on new MS drug

By staff reporter

Avecia Biologics has signed a development and manufacturing deal
with US firm BaroFold, making use of the company's protein
processing technology to produce its lead interferon-based multiple
sclerosis (MS) candidate.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All